ABSTRACT
R
ecent studies have shown that the status of collaterals and clot burden evaluated with multidetector row CT can be used as 2 independent parameters to predict both the success of revascularization and the ultimate clinical outcome of patients with acute ischemic stroke (AIS). [1] [2] [3] [4] Thus, these 2 parameters can be used as potentially valuable metrics for the selection of appropriate candidates for endovascular thrombectomy. 5, 6 However, the acquisition of multidetector row CT images to assess clot burden and collaterals may delay the time from stroke onset to revascularization; this delay is primarily due to the time needed to transfer patients among different sites in a clinical facility. As a result, acquisition of complete anatomic and physiologic imaging for a comprehensive diagnosis and evaluation of eligible patients becomes a reluctant option in the current clinical practice. It would be ideal to acquire all the needed imaging information for AIS directly in an angiography suite (ie, a "one-stop-shop" imaging workflow in the angiography suite), to avoid delay while performing comprehensive evaluations of patients with AIS. Recently, with a C-arm conebeam CT (CBCT) acquisition platform in the angiographic suite, the feasibility of acquiring dynamic CBCT perfusion (CBCTP) maps in the angiography suite has been demonstrated both in animals and in human subjects. 7, 8 From the acquired CBCT perfusion dataset, time-resolved conebeam CT angiography (CBCTA) can also be generated to provide accurate diagnosis of large-vessel occlusions (LVOs). 9, 10 In this study, we hypothesized that the use of timeresolved CBCTA would facilitate the evaluation of collateral status and clot burden in patients with AIS. This hypothesis was tested with the time-resolved CBCTA generated by novel imageprocessing algorithms from a CBCTP acquisition in the angiography suite. 11, 12 The ability to accurately and reliably assess collateral status and clot burden by using time-resolved CBCTA would, in our opinion, further enrich the environment of the angiography suite as a one-stop-shop for AIS care.
MATERIALS AND METHODS

Patient Selection
Under an approved ethics committee protocol at University of Erlangen-Nuremberg, 17 consecutive patients with AIS with suspected LVO underwent both conventional pretreatment imaging (multidetector row CTP or MRP) and dynamic C-arm CBCTP examinations. During treatment procedures, these patients also underwent conventional DSA imaging as part of the standard of care. All patient imaging and data collection was performed at the University Hospital of the University of Nuremberg-Erlangen. Ten of these subjects had C-arm CBCTP datasets acquired before endovascular treatment. Data from these subjects were completely anonymized and shared with the team at the University of Wisconsin School of Medicine and Public Health. These are the subjects included in this study. These subjects had 4 ICA occlusions, 3 M1 occlusions, 2 M2 occlusions, and 1 basilar trunk occlusion. Details of data acquisition and data postprocessing follow below.
Data Acquisition
The details of the technique for obtaining the CBCTP data have been reported elsewhere. 9, 10 Briefly, the dynamic C-arm CBCTP data were acquired by using a biplane flat detector angiographic system (Axiom Artis zee; Siemens, Erlangen, Germany). Contrast was injected into a peripheral vein with a dual-syringe angiographic power injector (Accutron HP-D; Medtron, Saarbrücken, Germany). Sixty milliliters of contrast material (iopamidol, Imeron 350; Bracco, Milan, Italy) was injected at a rate of 5 mL/s followed by a 60-mL saline flush. Nine bidirectional rotational scans (5 forward rotations and 4 reverse rotations) were obtained for each subject; contrast was injected 5 seconds after the start of the acquisition so that the first 2 rotations served as the nonenhanced (mask) images, while the following 7 were contrast-enhanced (fill) images.
Image Postprocessing
3D isotropic filtered back-projection image volume for each rotation was reconstructed and coregistered with the proprietary software of the vendor. To reduce noise and improve temporal resolution and temporal sampling density, we used Prior Image Constrained Compressed Sensing and Temporal Resolution and Sampling Recovery techniques 11, 12 to generate time-resolved image volumes with better image quality and a half-second temporal resolution. Then, temporal maximum-intensity-projection (tMIP) image volumes were generated from time-resolved image volumes by assigning each image voxel the maximum value along the temporal direction. Both time-resolved and tMIP image volumes were imported into a Leonardo workstation (Siemens) for future measurement and evaluation.
Image Evaluation
Clot burden and collateral flow were evaluated by 2 experienced raters (30 and 8 years of experience in neurointervention) by consensus. Temporal MIP images were used to detect the proximal and distal sites of vessel occlusion to score the clot burden, 13 measure the thrombus length and size of distal vessel, and evaluate collateral status. Collateral status was evaluated by using 3 commonly used scoring systems. 4, 13, 14 Time-resolved image volumes were also displayed in MIP mode and used to evaluate the flow direction (antegrade or retrograde) of the MCA occlusions and also to generate time-density curves for selected symmetric measuring points on the bilateral MCA branches. From these timedensity curves, the differences of time-to-peak and peak density between the lesion and normal sides could be quantified. These parameters were of interest because they may reflect the differences of flow velocity and volume, respectively. The criterion standard used to identify the site of occlusion was the clinician's report of the 2D DSAs, which were performed at the start of treatment.
Statistics
Intraclass correlation analysis was performed by using SPSS, Version 20.0 (IBM, Armonk, New York). The Cronbach ␣ coefficients were calculated to assess the interrater agreement on the subjective evaluation of the capability and potential of this novel technique. Alpha values were interpreted according to the following criteria: unacceptable (␣ Ͻ .5), poor (0.5 Յ ␣ Ͻ .6), fair (0.6 Յ ␣ Ͻ .7), good (0.7 Յ ␣ Ͻ .9), and excellent (␣ Ն .9).
RESULTS
The full extent of vessel occlusion (ie, the proximal and distal occlusion sites) could be determined by using tMIP images for all 10 patients. In 7 of these patients, the length of the thrombus could be measured (7 with terminal ICA, M1, basilar trunk, or M2 occlusions) and the measured lengths ranged from 5.9 to 19.9 mm. In the 3 patients with cervical or cavernous ICA occlusion, thrombus length could not be measured due to the tortuous course of the ICA and the presence of streaking artifacts over the cavernous or cervical portions of the artery. Clot burden could thus be qualitatively evaluated for 6 patients by using a clot-burden score designed specifically for LVOs in the anterior circulation. 13 The diameter of the occluded vessel distal to the thrombus could be measured for all patients ( Table 1) . The evaluation of collateral flow was successfully performed for 7 patients with LVOs in the anterior circulation (4 ICAs, 3 M1s). In all of these patients, the extent of collateral flow could be assessed by using the tMIP images, regardless of which scoring system was used (Table 2) . 4, 13, 14 Antegrade flow into the down-stream vascular territory was detected in 3 patients. Analysis of time-density curves documented the late arrival of contrast by collateral flow with a difference of 1.5-10 seconds in time-to-peak and a reduction in peak density between 9.2% and 42%. We believe that the latter reflects the reduced blood flow volume. Two raters were in full agreement that the ability to evaluate clot burden and collateral flow with time-resolved C-arm CBCTA was equal to or better than that of the conventional techniques. They were also in good agreement that with the C-arm CBCTAs, additional information was available that could not be obtained from the conventional techniques (ie, clot distribution and dynamic information on collateral flow, ␣ ϭ 1). Therefore, the 2 raters preferred the CBCTAs for evaluation of clot burden and collateral flow (␣ ϭ 1).
DISCUSSION
In this feasibility study, we have demonstrated the ability to evaluate collateral status and clot burden by using time-resolved C-arm CBCTAs derived from C-arm CBCTP acquisitions. On the basis of our experience, this novel technique enabled us to evaluate collateral score and clot burden in a more comprehensive manner than currently available methods (ie, multidetector row CT or MRA). The availability of time-resolved C-arm CBCTAs and tMIP images that are derived from CBCTP acquisitions acquired at the site of treatment further enhances the angiographic suite as a one-stopshop for the care of patients with AIS.
Several modalities have been used for the evaluation of collateral status (eg, DSA, CT, MR imaging, and transcranial Doppler). Although DSA allows assessment of anatomic and dynamic features of collateral flow, it is usually reserved for those patients selected for endovascular treatment. Full evaluation of collaterals with DSA also requires the catheterization of multiple arteries for full collateral assessment. The advantage of the C-arm time-resolved conebeam CTA over 2D DSA is due to the following reasons: 1) the ability to provide a global (3D instead of 2D) view of collaterals with a single IV injection rather than by a series of intra-arterial injections, and 2) the ability to provide time-resolved conebeam CTAs viewable from any desired angle at the point of treatment. Previous studies have shown that conventional CTAs may underestimate the collateral flow, overestimate the clot burden, and lack dynamic information compared with time-resolved 4D-CTAs.
15-17 4D-CTA is only used occasionally due to its current limited availability. Compared with these 4D-CTAs, C-arm CBCTAs derived from C-arm CBCTP acquisitions are fully time-resolved. C-arm time-resolved CBCTAs not only provide static (anatomic) information but also dynamic (blood flow) information about collateral flow. Temporal MIP images, a fusion of every single-phase image of time-resolved CTA, can also be generated from the time-resolved CBCTA data as shown in Figs 1 and 2B . The availability of time-resolved CBCTAs at the point of treatment is, in our opinion, a clear advantage over conventional CTAs Note:-R indicates right; L, left; NA, not applicable. a The clot is located in a bifurcation site, where there are 2 distal ends and subsequently 2 measurements for both thrombus length and diameter of the distal vessel. (the dynamic information about antegrade or retrograde collateral filling allowed us to see downstream filling in 3patients). If we had only conventional CTAs, this would not have been possible. These series were shown to be superior to conventional singlephase CTA for visualization of both collateral flow and clot burden. 1, 15 Using the time-resolved MIP images, we were able to determine the direction of blood flow (antegrade or retrograde) (Fig 2A) and also generate time-density curves, which provide some quantitative information about blood flow velocity and volume (Fig 2C, -D) . Because they are acquired as an IV technique (thus including the full circulation), it seems likely that they will be preferable to intra-arterial DSA (with the requirement for multiple intra-arterial injections) as a means of acquiring this information. The C-arm CBCTAs have better spatial resolution than conventional CTAs and also provide whole-brain coverage, which is superior to most of the clinically used MDCTAs, 18 which are either static if the whole-brain coverage is needed or only a timeresolved series for a thin slab of brain anatomy. The whole-brain coverage ensures isotropic reconstructions from at least the level of the ICA bifurcation.
Thus, it is possible to obtain secondary reformats that provide images from any direction. This flexibility of secondary reconstruction from any view angle should help to evaluate accurately the distribution of the clot burden and the size and angulation of distal vessels for any LVOs (Fig 1) . This information can, in principle, facilitate accurate selection of the size and deploying site of a stent or thrombectomy device and could thus shorten the groin puncture-to-revascularization time. More important, time-resolved C-arm CBCTA can be directly derived from the CBCTP data acquisition in the angiography suite, thus eliminating the need to transfer patients among different locations in the hospital. This change should result in a meaningful reduction of the picture-to-puncture time from stroke onset to endovascular treatment time. Because of its technical advantages and availability at the point of treatment, in our opinion, this novel imaging technique has great potential as a new tool for the care of patients with AIS suspected of having an LVO.
This study has several limitations. First, there was no control group. We were thus unable to directly compare the CBCTAs against other techniques. Because this was only a feasibility study, we are not able to offer rigorous comparisons of CBCTAs with either MDCTAs (single or multiphase) or MRAs. Second, our sample size was small; this feature further limits the ability to understand the real utility of CBCTAs. We are working to establish a prospective multicenter study, which will eliminate these limitations and will allow validation of the technique in realworld clinical practice.
CONCLUSIONS
In this small feasibility study, evaluation of clot burden and collateral status was feasible by using time-resolved C-arm CBCTAs derived from CBCTP acquisitions obtained in the angiography suite. Our results suggest that this novel technique provides a more complete method for evaluation of these parameters than conventional modalities. 
